Chesterfield, Missouri-based Bunge Global SA (BG) is an integrated global agribusiness and food company. With a market cap of $10.8 billion, Bunge operates through Agribusiness, Refined and Specialty Oils, Milling, and Sugar and Bioenergy segments.

The agribusiness giant has significantly underperformed the broader market over the past year, but performed slightly better in 2025. BG stock prices have plummeted 21.4% over the past 52 weeks and gained 3.4% on a YTD basis, compared to the S&P 500 Index’s ($SPX) 11.9% surge over the past year and 1% uptick in 2025.

Narrowing the focus, Bunge has also underperformed the Consumer Staples Select Sector SPDR Fund’s (XLP) 6.4% gains over the past year and 5.1% returns on a YTD basis.

Bunge Global’s stock prices dropped 2.9% after the release of its lackluster Q1 results on May 7. The company’s volumes took a severe hit during the quarter, leading to a 13.2% year-over-year decline in net sales to $11.6 billion, missing the Street’s expectations by a large margin. Meanwhile, Bunge reported a staggering 44.7% year-over-year decrease in adjusted net income to $244 million. Furthermore, due to changes in working capital, the company reported a net cash outflow from operating activities of $285 million, significantly down from the inflows of $994 million reported in the year-ago quarter.

For the current FY 2025, ending in December, analysts expect Bunge to deliver an adjusted EPS of $7.74, down 15.8% compared to FY 2024. The company has a mixed earnings surprise history. While it surpassed the Street’s bottom-line projections twice over the past four quarters, it missed the estimates on two other occasions.

Among the seven analysts covering the BG stock, the consensus rating is a “Moderate Buy.” That’s based on four “Strong Buys” and three “Holds.”

This configuration has remained consistent in recent months.

On May 8, Stephens & Co. analyst Pooran Sharma reiterated an “Overweight” rating on Bunge, but reduced the price target from $90 to $85.

As of writing, Bunge’s mean price target of $85.88 represents a modest 6.8% premium to current price levels. While the street-high target of $100 suggests a notable 24.4% upside potential.